Off-the-Shelf CAR T Therapy for DLBCL: Key Facts
Off-the-shelf CAR T-cell therapy being tested in clinical trials aims to expand treatment access for diffuse large B-cell lymphoma patients by using healthy donor cells instead of a patient’s own harvested white blood cells. According to blood cancer specialist Dr. John M. Burke of the Rocky Mountain Cancer Center, autologous treatments require complex logistics and … Read more